Filing Details
- Accession Number:
- 0000950170-24-115380
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 17:14:46
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 17:14:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1308547 | Dolby Laboratories Inc. | DLB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200469 | J Kevin Yeaman | C/O Dolby Laboratories, Inc. 1275 Market Street San Francisco CA 94103 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-10-15 | 28,512 | $62.32 | 112,233 | No | 4 | M | Indirect | By a trust |
| Class A Common Stock | Disposition | 2024-10-15 | 18,696 | $73.90 | 93,537 | No | 4 | S | Indirect | By a trust |
| Class A Common Stock | Disposition | 2024-10-15 | 9,816 | $74.55 | 83,721 | No | 4 | S | Indirect | By a trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | By a trust |
| No | 4 | S | Indirect | By a trust |
| No | 4 | S | Indirect | By a trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2024-10-15 | 28,512 | $0.00 | 28,512 | $62.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 57,888 | 2024-12-15 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 120,320 | Direct |
Footnotes
- The shares held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 reported in the Form 4 filed for the Reporting Person on June 25, 2024 were incorrectly reported as 83,271. The correct amount was 83,721 at that time, and the shares held reported herein reflect the corrected amount.
- By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
- The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares held following the reported transactions include 120,320 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares.
Billionaire Hedge Funds
